Friday, June 19, 2026

Is South Korea the Most Vulnerable Emerging Market to U.S. Rate Hikes? Find Out!

South Korea is most vulnerable to U.S. interest rate shifts, with rising long-term yields impacting its bond market sensitivity.

Kim Jong Un Sends Birthday Wishes to Xi Jinping: What This Means for China-North Korea Relations

Kim Jong Un congratulated Xi Jinping on his birthday, while North Korea's industrial production reportedly surged by 105% post-party congress.

Novo Nordisk’s Oral Wegovy Just Put Up a Number That Could Change the Obesity Drug Race

Novo Nordisk's oral obesity treatment, Wegovy, saw $400M in Q1 2026 sales, exceeding estimates and indicating strong market demand.

Tag: SillaJen

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

Revolutionary Cancer Treatment SJ-650: What Makes It a Game Changer in Oncology?

SillaJen's SJ-650 cancer treatment platform gains recognition with publication in Molecular Therapy, showcasing its innovative approach and efficacy.

Top News

- Our Sponsors Ad -

Follow us